An INTENSIVE review of the The ACTT-1 Study of Remdesivir for patients with COVID-19 by Beigel et al, 2020.
Beigel et al, 2020 – Remdesivir: The ACTT-1 Study | INTENSIVE Review
Tag: vinodh nanjayya
Wang et al, 2020 – Remdesivir in adults with severe COVID-19 | INTENSIVE Review
INTENSIVE Review of Wang et al, 2020 – Remdesivir in adults with severe COVID-19; a multicentre RCT published in the Lancet.
Interpreting COVID-19 mortality outcomes | INTENSIVE Review
Essential points to consider while reviewing such papers which report on COVID-19 related mortality outcomes in ICU patients.